Study of hALK.CAR T Cells for Patients With Relapsed/Refractory High-risk Neuroblastoma — StellaPhase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(2 sites)
United States
Boston Children's Hospital, Boston, Massachusetts Dana-Farber Cancer Institute, Boston, Massachusetts Age range
12 Months – 29 Years
Last updated December 2025